Dr. Guillermo Umpierrez, Professor of Medicine at Emory University and President, Medicine & Science for the American Diabetes Association discusses the role that continuous glucose monitors and other technology play in current inpatient glycemic management and the impact that technology will have on future best practice care.
Key takeaways include:
Current evidence of CGM efficacy and safety
Clinical trials in ICU and non-ICU settings
CGM use during COVID-19 pandemic
Challenges for CGM adoption